hotspot -WSS

hotspot

author：entertainment 2025-09-30 20:06:00 - browse：82591

LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer.

AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday. If certain regulatory milestones are met, AstraZeneca will pay another $3 a share, or roughly $400 million.

Fusion specializes in developing radiopharmaceuticals, also known as radioconjugates or radioligands, which deliver radiation directly to tumors, guided by particular markers on cancer cells. The aim is not only to minimize the risk of damaging surrounding, healthy tissue, but also to reach tumors that traditional radiation can’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Decaf coffee targeted by food safety group under obscure FDA rule

entertainment

WSS

Primary care physicians play key roles in Alzheimer's management

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Primary care physicians play key roles in Alzheimer's management

How corporate America is slashing DEI workers amid backlash to diversity programs

Readout LOUD podcast: mifepristone case, GLP

States should stop sabotaging methadone treatment reform

hotspot

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

California man arrested in connection with serial murders of Mexican strip club workers

Supreme Court strikes down use of affirmative action

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What to know about a major upcoming Wegovy heart health study

Medical leaders decry Supreme Court decision on affirmative action

Vertex Pharmaceuticals may move headquarters in Boston

Hollywood unions extend contract negotiations for actors

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

hotspot

Drinking water from half of US faucets contains PFAS: Study

Patient advocates debate FDA's accelerated approval process

Rare Northern Lights show in US this week: Where and how to see it

Roche subsidiary Foundation Medicine opens new headquarters

Will generative AI in health care meet the fate of IBM's Dr. Watson?

North Korean leader's powerful sister says warplanes repelled US spy plane

explore

leisure time

entertainment

explore